Advertisement
KAVL vs XXII
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAVL is a Hold and XXII is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KAVL’s FA Score shows that 0 FA rating(s) are green whileXXII’s FA Score has 0 green FA rating(s).
- KAVL’s FA Score: 0 green, 5 red.
- XXII’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KAVL’s TA Score shows that 2 TA indicator(s) are bullish while XXII’s TA Score has 2 bullish TA indicator(s).
- KAVL’s TA Score: 2 bullish, 8 bearish.
- XXII’s TA Score: 2 bullish, 2 bearish.
Price Growth
KAVL (@Tobacco) experienced а -5.62% price change this week, while XXII (@Tobacco) price change was -21.48% for the same time period.
The average weekly price growth across all stocks in the @Tobacco industry was -0.57%. For the same industry, the average monthly price growth was -1.52%, and the average quarterly price growth was +22.11%.
Industries' Descriptions
@Tobacco (-0.57% weekly)The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.
| KAVL | XXII | KAVL / XXII | |
| Capitalization | 5.52M | 1.06M | 524% |
| EBITDA | -8.16M | N/A | - |
| Gain YTD | -47.625 | -97.486 | 49% |
| P/E Ratio | N/A | 0.00 | - |
| Revenue | 1.7M | N/A | - |
| Total Cash | 1.81M | 15M | 12% |
| Total Debt | 767K | 5.56M | 14% |
KAVL | XXII | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 49 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 91 | 98 | |
P/E GROWTH RATING 1..100 | 100 | 97 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XXII's Valuation (65) in the Miscellaneous industry is in the same range as KAVL (66) in the null industry. This means that XXII’s stock grew similarly to KAVL’s over the last 12 months.
XXII's Profit vs Risk Rating (100) in the Miscellaneous industry is in the same range as KAVL (100) in the null industry. This means that XXII’s stock grew similarly to KAVL’s over the last 12 months.
KAVL's SMR Rating (98) in the null industry is in the same range as XXII (100) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.
KAVL's Price Growth Rating (91) in the null industry is in the same range as XXII (98) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.
XXII's P/E Growth Rating (97) in the Miscellaneous industry is in the same range as KAVL (100) in the null industry. This means that XXII’s stock grew similarly to KAVL’s over the last 12 months.
| KAVL | XXII | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | N/A |
| Stochastic ODDS (%) | 3 days ago 81% | N/A |
| Momentum ODDS (%) | 3 days ago 90% | N/A |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 5 days ago 83% | 18 days ago 76% |
| Declines ODDS (%) | 7 days ago 90% | 6 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 90% | N/A |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 90% |
Advertisement
KAVL and
Correlation & Price change
A.I.dvisor tells us that KAVL and PYYX have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAVL and PYYX's prices will move in lockstep.
| Ticker / NAME | Correlation To KAVL | 1D Price Change % | ||
|---|---|---|---|---|
| KAVL | 100% | +2.35% | ||
| PYYX - KAVL | 11% Poorly correlated | +0.19% | ||
| RLX - KAVL | 11% Poorly correlated | -0.45% | ||
| XXII - KAVL | 5% Poorly correlated | +4.07% | ||
| CHUC - KAVL | 3% Poorly correlated | N/A | ||
| BATMF - KAVL | 2% Poorly correlated | N/A | ||
More | ||||
XXII and
Correlation & Price change
A.I.dvisor indicates that over the last year, XXII has been loosely correlated with SMORF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XXII jumps, then SMORF could also see price increases.
| Ticker / NAME | Correlation To XXII | 1D Price Change % | ||
|---|---|---|---|---|
| XXII | 100% | +4.07% | ||
| SMORF - XXII | 42% Loosely correlated | N/A | ||
| RLX - XXII | 12% Poorly correlated | -0.45% | ||
| BTAFF - XXII | 11% Poorly correlated | +0.70% | ||
| TPB - XXII | 11% Poorly correlated | +0.38% | ||
| UVV - XXII | 7% Poorly correlated | +0.04% | ||
More | ||||